Skip to main content
TipRanks
Go Ultimate75% OFF

Tanvex Biopharma (6541) Cash flow

Tanvex Biopharma Cash Flow

TW:6541's free cash flow for Q2 2026 was NT$-282.94M. For the 2026 fiscal year, TW:6541's free cash flow was decreased by NT$-45.07M and operating cash flow was NT$-237.87M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
NT$ -1.01BNT$ -1.15BNT$ -1.43BNT$ -1.33BNT$ -1.39B
NT$ 301.80MNT$ -109.25MNT$ -83.57MNT$ -97.35MNT$ -24.68M
NT$ 1.14BNT$ 1.26BNT$ 1.08BNT$ -123.29MNT$ 1.60B
NT$ 878.71MNT$ 376.96MNT$ 380.75MNT$ 786.23MNT$ 2.22B
NT$ -1.68BNT$ -1.26BNT$ -1.51BNT$ -1.43BNT$ -1.42B

Currency in TWD

Tanvex Biopharma Cash Flow

-3B-2B-1B01B2B3B201720182019202020212022202320242025OperatingInvestingFinancing